Abstract:Objective To observe effect of microRNA-218 (miR-218) targeting SOX5 on the growth and invasiveness of glioblastoma cells.Methods U87 glioma cell lines were cultured,and they were divided into a control group,a nonsense sequence group and a miR-218 mimics transfection group.Forty glioma tissue specimens and 35 normal brain tissue samples were selected.The biological information method and the luciferase report system were used to verify that SOX5 was the direct acting target of miR-218.The effect of miR-218 on mRNA and protein expression of SOX5 in U87 cells,glioma tissue and their normal brain tissue were detected by RT-PCR and Western blot.After overexpressing miR-218 in U87 cells,the changes of U87 cell phenotype were detected by using the MTT experiment and Tanswell experiment.Results Compared with the control and the nonsense sequence groups,the relative expression quantity of miRNA-218 increased about 42.23 times in the miRNA-218 mimics transfection group.The results of MTT assay showed that the growth of glioma cells was inhibited significantly after overexpreesing miRNA-218.The cell proliferation rate of at day 5 was only 49.2％.The results of Transwell assay showed that the number of cells passing through the Transwell chambers was 13.0 ± 2.1.It was lower than 35.0 ± 2.3 and 32.0 ± 3.1 in the control and the nonsense sequence groups (all P ＜ 0.05).The biological information predicted that the SOX5 was one of the target genes of miR-218.UTR contained the binding site of miR-218 in SOX5 3'.The dual luciferase assays indicated that SOX5 was the direct acting target of miR-218.After overexpressing miR-218,RT-PCR and Western blot showed that the expression of SOX5 mRNA and protein in the miR-218 mimics transfection group was significantly lower than that the control and the nonsense sequence groups.There was significant difference (P ＜ 0.01).After silencing SOX5,the results of the MTT assay showed that the cell increment rate of the siRNA-SOX5 group at day 5 of cell culture was only 51.0％ in the siControl group.The Transwell assay analysis showed that the number of cells passing through Transwell chambers in the siRNA-SOX5 group was 12.0 ± 1.3,and it was lower than 23.0 ± 2.0 in the siControl group (P ＜ 0.05).Conclusions SOX5 is the target gene of miR-218 and it was negatively regulated by it.miR-218 may play an important role in pathogenesis of glioma through targeting SOX5.

SOX15 Exerts Antitumor Function in Glioma by Inhibiting Cell Proliferation and Invasion Via Downregulation of Wnt/β-catenin Signaling.

SOX9+ malignant cells define a poor prognosis subtype of Glioma with tumor-associated macrophage recruitment

SOX1 Inhibits Breast Cancer Cell Growth and Invasion Through Suppressing the Wnt/β-catenin Signaling Pathway.

SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling

Effects of SOX15 on the colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.

SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer

Sohlh1 Suppresses Glioblastoma Cell Proliferation, Migration, and Invasion by Inhibition of Wnt/β‐catenin Signaling

Long Noncoding RNA AB073614 Promotes the Malignance of Glioma by Activating Wnt/β-catenin Signaling Through Downregulating SOX7.

Knockdown of SOX2OT Inhibits the Malignant Biological Behaviors of Glioblastoma Stem Cells Via Up-Regulating the Expression of Mir-194-5p and Mir-122

SOX18 Exerts Tumor-Suppressive Functions in Papillary Thyroid Carcinoma Through Inhibition of Wnt/β-catenin Signaling

Sox15 Methylation Inhibits Cell Proliferation Through Wnt Signaling in Hepatocellular Carcinoma

SOX4 Inhibits GBM Cell Growth and Induces G0/G1 Cell Cycle Arrest Through Akt-p53 Axis.

ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma

TGF-β Signaling Promotes Glioma Progression Through Stabilizing Sox9

TBX15 facilitates malignant progression of glioma by transcriptional activation of TXDNC5

Expression and Significance of SOX B1 Genes in Glioblastoma Multiforme Patients

SOX10, a Novel HMG-box-containing Tumor Suppressor, Inhibits Growth and Metastasis of Digestive Cancers by Suppressing the Wnt/β-catenin Pathway.

HOXC10 Promotes Proliferation and Invasion and Induces Immunosuppressive Gene Expression in Glioma

Effect of Microrna-218 Targeting SOX5 on the Growth and Invasiveness of Glioblastoma Cells

Gene Expression Profile Analysis of U251 Glioma Cells with Shrna-Mediated SOX9 Knockdown.

SOX7 is associated with the suppression of human glioma by HMG-box dependent regulation of Wnt/β-catenin signaling